Exclusive

Publication

Byline

Location

Light Science Technologies Expects FY26 Revenue Below Expectations, Shares Down

India, Oct. 1 -- On Thursday, Light Science Technologies Holdings Plc (LST.L), a business solutions provider, published a trading update for the year of 2026. The Company now expects 2026 revenue of ... Read More


Sun Pharma Reports Two-Year LEQSELVI Data In Severe Alopecia Areata

India, Oct. 1 -- Thursday, Sun Pharmaceutical Industries Limited (SUNPHARMA) reported two-year safety and efficacy data for LEQSELVI (deuruxolitinib) in adults with severe alopecia areata at the 2026 ... Read More


Hyundai Motor America Sales Rise In September, Q3 2026

India, Oct. 1 -- Thursday, Hyundai Motor Company (005380.KS) announced a record September total sales of 77,439 units in America, an increase of 9 percent from last year. The September sales were led... Read More


U.S. Stocks Mostly Lower As Crude Oil Extends Yesterday's Jump

India, Oct. 1 -- After failing to sustain an initial move to the upside, stocks have moved mostly lower over the course of the trading session on Thursday. The major averages have all moved to the dow... Read More


Akari Expands IP Portfolio With PCT Filing For PH1 ADC Payload

India, Oct. 1 -- On Thursday, Akari Therapeutics (AKTX) said it filed a new PCT application covering its PH1 payload and its ability to disrupt multiple cancer-driving pathways through RNA splicing mo... Read More


IBM Stock Rises 4% After Expanding Bob AI Platform To Self-Hosted Environments

India, Oct. 1 -- International Business Machines Corp. (IBM) is up 4.22 percent, gaining $9.29 to $229.22 on Thursday. The move comes after IBM announced a self-hosted deployment option for IBM Bob, i... Read More


Candel's Aglatimagene Shows Prolonged Survival In Phase 2a NSCLC Trial

India, Oct. 1 -- Thursday, Candel Therapeutics (CADL) reported final Phase 2a data for aglatimagene besadenovec plus valacyclovir in patients with unresectable Stage III/IV non-small cell lung cancer ... Read More


Candel Reports 24.5-Month Survival In Phase 2a NSCLC Study

India, Oct. 1 -- Candel Therapeutics (CADL) reported final Phase 2a results showing a median overall survival of 24.5 months with aglatimagene besadenovec plus valacyclovir in patients with advanced N... Read More


U.S. Construction Spending Unexpectedly Increases In August

India, Oct. 1 -- A report released by the Commerce Department on Thursday showed an unexpected increase in U.S. construction spending in the month of August. The Commerce Department said construction... Read More


U.S. Manufacturing Index Edges Lower In September But Still Indicates Growth

India, Oct. 1 -- Manufacturing activity in the U.S. expanded for the ninth consecutive month in September, according to a report released by the Institute for Supply Management on Thursday. The ISM s... Read More